基于分区生存模型的尼妥珠单抗一线治疗K-Ras野生型晚期胰腺癌的经济学评价
黄金龙, 叶晗鋆, 林敬阳, 罗丹, 郑小春
Economic evaluation of nimotuzumab for the first-line treatment of K-Ras wild-type advanced pancreatic cancer based on the partitioned survival model
HUANG Jinlong, YE Hanyun, LIN Jingyang, LUO Dan, ZHENG Xiaochun
中国医院药学杂志
.
2026, (2): 175
-180
.
DOI: 10.13286/j.1001-5213.2026.02.08
